A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study

A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study

<p>Abstract</p> <p>Background</p> <p>In premenopausal women, endocrine adjuvant therapy for breast cancer primarily consists of tamoxifen alone or with ovarian suppressive strategies. Toremifene is a chlorinated derivative of tamoxifen, but with a superior risk-benefit...

Full description

Bibliographic Details
Main Authors: Gu Ran, Jia Weijuan, Zeng Yunjie, Rao Nanyan, Hu Yue, Li Shunrong, Wu Jiannan, Jin Liang, Chen Lijuan, Long Meijun, Chen Kai, Chen Lili, Xiao Qiaozhen, Wu Mei, Song Erwei, Su Fengxi
Format: Article
Language:English
Published: BMC 2012-05-01
Series:BMC Cancer
Subjects:
Tamoxifen
Toremifene
Breast cancer
Adjuvant endocrine therapy
Premenopausal
Online Access:http://www.biomedcentral.com/1471-2407/12/161

Internet

http://www.biomedcentral.com/1471-2407/12/161

Similar Items